Galectin Therapeutics shares owned by Geneos Wealth Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Geneos Wealth Management
from 13F filings
Historical chart of Geneos Wealth Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Geneos Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Galectin Therapeutics by Geneos Wealth Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $890k | 394k | 2.26 |
2024-03-31 | $977k | 409k | 2.39 |
2023-12-31 | $685k | 413k | 1.66 |
2023-09-30 | $801k | 417k | 1.92 |
2023-06-30 | $607k | 422k | 1.44 |
2023-03-31 | $898k | 427k | 2.10 |
2022-12-31 | $491k | 435k | 1.13 |
2022-09-30 | $725k | 445k | 1.63 |
2022-06-30 | $626k | 478k | 1.31 |
2022-03-31 | $764k | 475k | 1.61 |
2021-12-31 | $995k | 481k | 2.07 |
2021-09-30 | $1.9M | 491k | 3.80 |
2021-06-30 | $1.6M | 492k | 3.17 |
2021-03-31 | $2.3M | 512k | 4.42 |
2020-12-31 | $961k | 486k | 1.98 |
2020-09-30 | $101k | 37k | 2.73 |
2020-06-30 | $108k | 37k | 2.92 |
2020-03-31 | $80k | 42k | 1.92 |
2019-12-31 | $126k | 44k | 2.88 |
2019-09-30 | $160k | 44k | 3.62 |
2019-06-30 | $220k | 53k | 4.14 |
2019-03-31 | $284k | 56k | 5.10 |
2018-12-31 | $224k | 60k | 3.76 |
2018-09-30 | $358k | 60k | 6.00 |
2018-06-30 | $78k | 12k | 6.32 |
2018-03-31 | $196k | 41k | 4.74 |
2017-12-31 | $245k | 74k | 3.33 |
2017-09-30 | $146k | 69k | 2.13 |
2017-06-30 | $149k | 61k | 2.46 |
2017-03-31 | $130k | 57k | 2.30 |
2016-12-31 | $51k | 53k | 0.97 |
2016-09-30 | $57k | 51k | 1.12 |
2016-06-30 | $77k | 51k | 1.52 |
2016-03-31 | $73k | 51k | 1.44 |